Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways

Prostate cancer treatment is based on the stratification of disease as low-, intermediate- or high-risk. This stratification has been largely based on anatomic pathology of the disease, as well as through the use of prostate specific antigen (PSA). However, despite this stratification, there remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Eidelman, Eric, Tripathi, Hemantkumar, Fu, De-Xue, Siddiqui, M. Minhaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178321/
https://www.ncbi.nlm.nih.gov/pubmed/30363493
http://dx.doi.org/10.21037/tau.2018.04.08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178321/
https://www.ncbi.nlm.nih.gov/pubmed/30363493
http://dx.doi.org/10.21037/tau.2018.04.08

Ejemplares similares